Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy

Clinically stable patients with PCD show changes in sputum viscoelastic properties, inflammation markers and the proteome that are less severe than in patients with CF at baseline, but comparable to CF patients on ETI therapy.

Authors

Institutions

Publication Details

Journal
European Respiratory Journal
Published
2025-09-18
DOI
https://doi.org/10.1183/13993003.00616-2025
Citations
8
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
12.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy

Kerstin Fentker, Ruth Maria Urbantat, Laura Schaupp, Philipp Mertins et al.
8 citations
European Respiratory Journal
Cystic Fibrosis Research Advances
12.15
article

Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy

Kerstin Fentker, Ruth Maria Urbantat, Laura Schaupp, Philipp Mertins, Jobst Roehmel, Mohamed Haji, Axel Loewe, Felix Doellinger, Marcus Alexander Mall, Simon Y. Graeber, Mirjam Stahl, Julia Duerr, Michael Gradzielski, Hannah Nussstein
article en
8 citations

Abstract

Clinically stable patients with PCD show changes in sputum viscoelastic properties, inflammation markers and the proteome that are less severe than in patients with CF at baseline, but comparable to CF patients on ETI therapy.

European Respiratory JournalVol. 67(2)
American Institute of Biological Sciences (US), Max Delbrück Center (DE), Major League Baseball (US), Humboldt-Universität zu Berlin (DE), German Center for Lung Research (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Technische Universität Berlin (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
European Respiratory Society, Vertex Pharmaceuticals, Insmed, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Berlin Institute of Health
Openalex Percentile: Top 1%
Cystic Fibrosis Research Advances
12.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.